Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of lurasidone in acute schizophrenia
2007-003819-31Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lurasidone in schizophrenia (4 arms), sponsored by Sumitomo Pharma. Primary endpoints: Change from baseline in PANSS total score at Week 6 and Change from baseline in CGI-S at Week 6. Started Jan 2008; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-003819-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003819-31.